L-669,262, A POTENT HMG-COA REDUCTASE INHIBITOR

被引：8
|
作者：
JOSHUA, H
SCHWARTZ, MS
WILSON, KE
机构：
[1] Merck Sharp & Dohme Research Laboratories, Rahway, N.J. 07065, Inc., P. O. Box 2000
来源：
JOURNAL OF ANTIBIOTICS | 1991年 / 44卷 / 03期
关键词：
D O I：
10.7164/antibiotics.44.366
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The microbial transformation of simvastatin (MK-733) by Nocardia autotrophica subspecies amethystina yielded iso-simvastatin-6-one as a minor component. This transformation product is a dienone and is one of the more potent inhibitors of 3-hydroxy-3-methylglutaryl coenzyme. A reductase found to date.
引用
收藏
页码：366 / 370
页数：5
相关论文
共 50 条
  • [41] SYNTHESIS OF AN HMG-COA REDUCTASE INHIBITOR - A DIASTEREOSELECTIVE ALDOL APPROACH
    LYNCH, JE
    VOLANTE, RP
    WATTLEY, RV
    SHINKAI, I
    TETRAHEDRON LETTERS, 1987, 28 (13) : 1385 - 1388
  • [42] The effect of the HMG-CoA reductase inhibitor, simvastatin, on the renal microcirculation
    Inman, SR
    Caprio, TW
    Drummond, EE
    Mueller, ME
    FASEB JOURNAL, 2005, 19 (05): : A1145 - A1146
  • [43] Cerivastatin approval expands HMG-CoA reductase inhibitor choices
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (16) : 1793 - 1793
  • [44] Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia
    Isaacsohn, J
    Hunninghake, D
    Schrott, H
    Dujovne, CA
    Knopp, R
    Weiss, SR
    Bays, H
    Crouse, JR
    Davidson, MH
    Keilson, LM
    McKenney, J
    Korenman, SG
    Dobs, AS
    Stein, E
    Krauss, RM
    Maccubbin, D
    Cho, M
    Plotkin, DJ
    Mitchel, YB
    CLINICAL CARDIOLOGY, 2003, 26 (01) : 18 - 24
  • [45] Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin
    Muck, W
    Ritter, W
    Ochmann, K
    Unger, S
    Ahr, G
    Wingender, W
    Kuhlmann, J
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (06) : 255 - 260
  • [46] Effects of HMG-CoA Reductase Inhibitor on Experimental Autoimmune Myocarditis
    Xiaoman Liu
    Bo Li
    Wenke Wang
    Cheng Zhang
    Mingxiang Zhang
    Yun Zhang
    Yanfei Xia
    Zhe Dong
    Yuan Guo
    Fengshuang An
    Cardiovascular Drugs and Therapy, 2012, 26 : 121 - 130
  • [47] New and efficient synthesis of the HMG-CoA reductase inhibitor pitavastatin
    Acemoglu, Murat
    Brodbeck, Andre
    Garcia, Angel
    Grimler, Dorninique
    Hassel, Marc
    Riss, Bernhard
    Schreiber, Robert
    HELVETICA CHIMICA ACTA, 2007, 90 (06) : 1069 - 1081
  • [48] Rapid effect of HMG-CoA reductase inhibitor on endothelial function
    Lee, Y. S.
    Kim, K. S.
    Nam, C. W.
    Han, S. W.
    Hur, S. H.
    Kim, Y. N.
    Kim, K. B.
    EUROPEAN HEART JOURNAL, 2006, 27 : 494 - 494
  • [49] Effects of HMG-CoA Reductase Inhibitor on Experimental Autoimmune Myocarditis
    Liu, Xiaoman
    Li, Bo
    Wang, Wenke
    Zhang, Cheng
    Zhang, Mingxiang
    Zhang, Yun
    Xia, Yanfei
    Dong, Zhe
    Guo, Yuan
    An, Fengshuang
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (02) : 121 - 130
  • [50] CORRECTION OF NEPHROTIC HYPERCHOLESTEROLEMIA WITH THE HMG-COA REDUCTASE INHIBITOR LOVASTATIN
    GOLPER, TA
    ILLINGWORTH, DR
    BENNETT, WM
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 136 - 136
12345